SK286049B6 - Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie - Google Patents

Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie Download PDF

Info

Publication number
SK286049B6
SK286049B6 SK1871-2000A SK18712000A SK286049B6 SK 286049 B6 SK286049 B6 SK 286049B6 SK 18712000 A SK18712000 A SK 18712000A SK 286049 B6 SK286049 B6 SK 286049B6
Authority
SK
Slovakia
Prior art keywords
hyperforin
derivatives
extract
pharmaceutical composition
composition containing
Prior art date
Application number
SK1871-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK18712000A3 (sk
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of SK18712000A3 publication Critical patent/SK18712000A3/sk
Publication of SK286049B6 publication Critical patent/SK286049B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/647—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring
    • C07C49/653—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring polycyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
SK1871-2000A 1998-06-10 1999-06-04 Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie SK286049B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001312A IT1301679B1 (it) 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono.
PCT/EP1999/003880 WO1999064388A1 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them

Publications (2)

Publication Number Publication Date
SK18712000A3 SK18712000A3 (sk) 2001-06-11
SK286049B6 true SK286049B6 (sk) 2008-01-07

Family

ID=11380210

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1871-2000A SK286049B6 (sk) 1998-06-10 1999-06-04 Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie

Country Status (23)

Country Link
US (1) US6656510B2 (zh)
EP (2) EP1607099A1 (zh)
JP (1) JP4511726B2 (zh)
KR (1) KR100627933B1 (zh)
CN (1) CN1246278C (zh)
AT (1) ATE307103T1 (zh)
AU (1) AU763889B2 (zh)
BR (1) BR9910893B1 (zh)
CA (1) CA2334308C (zh)
CZ (1) CZ298859B6 (zh)
DE (1) DE69927813T2 (zh)
DK (1) DK1086071T3 (zh)
ES (1) ES2249893T3 (zh)
HK (1) HK1036791A1 (zh)
HU (1) HUP0102226A3 (zh)
IL (2) IL140151A0 (zh)
IT (1) IT1301679B1 (zh)
MX (1) MXPA00012177A (zh)
NO (1) NO328444B1 (zh)
PL (1) PL195797B1 (zh)
RU (1) RU2240304C2 (zh)
SK (1) SK286049B6 (zh)
WO (1) WO1999064388A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1770700A (en) * 1998-11-04 2000-05-22 Dr. Willmar Schwabe Gmbh & Co Stable preparations with hyperforin
ITMI20020872A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati dell'iperforina loro uso e formulazioni che li contengono
ITMI20020871A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati alogenati dell'iperforina loro uso e formulazioni che li contengono
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
BRPI0900614A2 (pt) 2009-02-13 2011-06-28 Univ Fed Do Rio Grande Do Sul Ufrgs extrato vegetal neuroativo, composição farmacêutica compreendendo o mesmo e processo para sua produção
CN103732568A (zh) * 2011-06-03 2014-04-16 哈佛大学的校长及成员们 贯叶金丝桃素类似物、其合成方法及其用途
ITMI20131012A1 (it) 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
RU2676100C1 (ru) * 2018-10-05 2018-12-26 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Применение производных пиперазина для лечения болезни Альцгеймера и деменций альцгеймеровского типа с нарушенной внутриклеточной кальциевой сигнализацией

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550266A (en) * 1948-12-11 1951-04-24 Swift & Co Preservation of food products
DE4239959A1 (de) * 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
DE19646977A1 (de) * 1995-09-29 1998-01-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
DE19714450A1 (de) * 1997-04-08 1998-10-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
CA2317671A1 (en) * 1998-01-13 1999-07-22 Rexall Sundown, Inc. St. john's wort and methyl donor composition and uses thereof
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition

Also Published As

Publication number Publication date
PL344696A1 (en) 2001-11-19
AU763889B2 (en) 2003-07-31
US6656510B2 (en) 2003-12-02
MXPA00012177A (es) 2004-09-06
ITMI981312A1 (it) 1999-12-10
CZ20004562A3 (en) 2001-06-13
DK1086071T3 (da) 2006-01-23
CA2334308C (en) 2009-06-02
DE69927813D1 (de) 2006-03-02
IL140151A0 (en) 2002-02-10
PL195797B1 (pl) 2007-10-31
KR100627933B1 (ko) 2006-09-22
IL140151A (en) 2006-12-10
NO328444B1 (no) 2010-02-22
HUP0102226A3 (en) 2003-07-28
NO20006230L (no) 2001-02-01
CZ298859B6 (cs) 2008-02-27
DE69927813T2 (de) 2006-04-20
BR9910893B1 (pt) 2013-10-29
AU4373999A (en) 1999-12-30
CN1304397A (zh) 2001-07-18
JP4511726B2 (ja) 2010-07-28
EP1086071B1 (en) 2005-10-19
KR20010052637A (ko) 2001-06-25
HK1036791A1 (en) 2002-01-18
US20010020040A1 (en) 2001-09-06
IT1301679B1 (it) 2000-07-07
ATE307103T1 (de) 2005-11-15
EP1607099A1 (en) 2005-12-21
WO1999064388A1 (en) 1999-12-16
JP2002517478A (ja) 2002-06-18
BR9910893A (pt) 2001-03-06
HUP0102226A2 (hu) 2001-10-28
NO20006230D0 (no) 2000-12-07
ES2249893T3 (es) 2006-04-01
CN1246278C (zh) 2006-03-22
SK18712000A3 (sk) 2001-06-11
RU2240304C2 (ru) 2004-11-20
EP1086071A1 (en) 2001-03-28
CA2334308A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
Desai et al. Charantin: An important lead compound from Momordica charantia for the treatment of diabetes
Yonathan et al. In vivo anti-inflammatory and anti-nociceptive activities of Cheilanthes farinosa
Mbeunkui et al. In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii
SK286049B6 (sk) Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie
US6428820B2 (en) Extracts of Hypericum perforatum and formulations containing them
FR2581310A1 (fr) Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
PT87234B (pt) Processo para a preparacao de extractos de frutos de serenoa repens consistindo em alcoois esterolicos e triterpenicos e de composicoes farmaceuticos que os contem
EP2226077B1 (en) Extract of Lycoris chejuenis and/or a compound isolated therefrom for preventing and/or treating a neurodegenerative disease
US6635672B1 (en) Agent for lowering prolactin
Saleem et al. Hypertensive and toxicological study of citric acid and other constituents from Tagetes patula roots
Kingsley et al. Anti-diabetic activity of active fractions of Stereospermum tetragonum DC and isolation of active principles
US9403786B2 (en) Anti-inflammatory compounds
JPH0952899A (ja) ロイコトリエン拮抗剤
Monsef-Esfahani et al. Antinociceptive effects of Paeonia daurica subsp. macrophylla root extracts in mice
JP2008044940A (ja) 樟芝（Ａｎｔｒｏｄｉａｃａｍｐｈｏｒａｔａ）の子実体より分離した新規な化合物およびその医薬組成物
KR100703596B1 (ko) 연수추출물 또는 그로부터 분리한캠프페롤-3-글루쿠로나이드를 함유하는 고지혈증의 예방 및치료용 조성물
JP2004256467A (ja) プロパン−１，２，３−トリオール誘導体、その製造方法およびそれを含むα−グルコシダーゼ阻害剤
FR2650999A1 (fr) Chlorhydrate de 1-(2-ethoxyethyl)-4-phenyl-4-propionyloxypiperidine

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130604